Abstracts tagged "Co-morbidities"

Abstract Number: 217 • 2018 ACR/ARHP Annual Meeting
Association between Comorbidities and Socioeconomic Status Among Patients with Rheumatoid Arthritis in Korea
Seunghwan Shin¹, Anna Shin¹, Ji Hyoun Kim², You-Jung Ha¹, Yun Jong Lee¹, Yeong Wook Song³ and Eun Ha Kang¹, ¹Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Gyeonggi-do, Korea, Republic of (South), ²Department of Internal Medicine, Chungbuk National University Hospital, Chungcheongbuk-do, Korea, Republic of (South), ³Seoul National University College of Medicine, Seoul, Korea, Republic of (South)
Background/Purpose: Increased prevalence of comorbidities in patients with rheumatoid arthritis (RA) compared to general population has been noted in several previous study. This study aims…
Abstract Number: 8L • 2017 ACR/ARHP Annual Meeting
Prevalence of Blindness in a Cohort of Rheumatologic Patients Treated with Hydroxychloroquine
Dilpreet Singh¹, Leila Muhieddine², Douglas Einstadter³ and Stanley Ballou⁴, ¹Rheumatology, Case Western Reserve University School of Medicine at MetroHealth Medical Center, Cleveland, OH, ²Internal Medicine, Case Western Reserve University, MetroHealth Medical Center, Cleveland, OH, ³Case Western Reserve University at MetroHealth Medical Center, Cleveland, OH, ⁴Rheumatology, Case Western Reserve University/MetroHealth Medical Center, Cleveland, OH

Background/Purpose: Hydroxychloroquine (HCQ) is widely used in the treatment of chronic rheumatic diseases. Its long-standing use has been associated with retinopathy in a daily and…
Abstract Number: 135 • 2017 ACR/ARHP Annual Meeting
Comorbidity Measures Differentially Predict Longitudinal Disease Activity, Remission, and Disability in Rheumatoid Arthritis
Bryant R. England¹, Harlan Sayles², Kaleb Michaud², Grant Cannon³, Andreas Reimold⁴, Liron Caplan⁵, Gail S. Kerr⁶, Namrata Singh⁷, Gleb Haynatzki⁸, Michael D. George⁹, Joshua Baker¹⁰ and Ted R. Mikuls¹¹, ¹Division of Rheumatology & Immunology, Department of Internal Medicine, Nebraska-Western IA VA Health Care System & University of Nebraska Medical Center, Omaha, NE, ²University of Nebraska Medical Center, Omaha, NE, ³Salt Lake City VA Medical Center and University of Utah, Salt Lake City, UT, ⁴Hospital of Southern Norway, Kristiansand, Norway, ⁵Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, ⁶VAMC, Georgetown University, Washington, DC, ⁷Internal Medicine, University of Iowa Hospitals and Clinics and Iowa City VA, Iowa City, IA, ⁸Biostatistics, University of Nebraska Medical Center, Omaha, NE, ⁹Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, ¹⁰Rheumatology, University of Pennsylvania, Philadelphia, PA, ¹¹Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE
Background/Purpose: Comorbidity frequently complicates rheumatoid arthritis (RA) leading to poor long-term outcomes. However, whether comorbidity influences measures of RA activity over time is less well…
Abstract Number: 136 • 2017 ACR/ARHP Annual Meeting
Prevalence of Rheumatoid Arthritis and Associated Comorbidities in the 2011-2015 Medicare Population
Suying Li, Julia T. Molony, Yi Peng, Kimberly M. Nieman and David T. Gilbertson, Minneapolis Medical Research Foundation, Chronic Disease Research Group, Minneapolis, MN
Background/Purpose: Rheumatoid arthritis (RA) is a systemic inflammatory disease affecting about 1.5 million adults in the US (Helmick et al., 2008). Patients with RA have…
Abstract Number: 723 • 2017 ACR/ARHP Annual Meeting
Incidence and Variability of Cardiovascular Risk Factors in Female Lupus Patients: A 3-Year Follow-up
Carolinne Monção¹, Leticia Martins¹, Marcela Penteado¹, Rodrigo Reis², Fabiana Miranda Moura dos Santos³, CRISTINA COSTA LANNA³, Antônio Luiz Ribeiro⁴ and Rosa Weiss Telles⁴, ¹Hospital das Clinicas, Universidade Federal of Minas Gerais, Belo Horizonte, Brazil, ²Universidade Federal of Minas Gerais, Belo Horizonte, Brazil, ³Medical School, Universidade Federal of Minas Gerais, Brazil, Belo Horizonte, Brazil, ⁴Medical School, Universidade Federal of Minas Gerais, Belo Horizonte, Brazil
Background/Purpose: To evaluate the incidence and variability of traditional coronary artery disease (CAD) risk factors in a cohort of systemic lupus erythematosus (SLE) patients. Methods:…
Abstract Number: 1160 • 2017 ACR/ARHP Annual Meeting
Increased Incidence of Upper and Lower Gastrointestinal Events in Patients with Sarcoidosis: A Population-Based Cohort Study
Patompong Ungprasert¹, Cynthia S. Crowson² and Eric L. Matteson³, ¹Rheumatology, Mayo Clinic, Rochester, MN, ²Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN, ³Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN
Increased Incidence of Upper and Lower Gastrointestinal Events in Patients with Sarcoidosis: A Population-Based Cohort StudyBackground/Purpose: An increased incidence of gastrointestinal (GI) events has…
Abstract Number: 1615 • 2017 ACR/ARHP Annual Meeting
Assessment of a Cognitive Impairment Measure in Systemic Lupus Erythematosus
Nicole Davidson¹, Alexa Meara², Holly Steigelman³, Songzhu Zhao⁴, Guy Brock⁵, Wael Jarjour⁶, Brad H. Rovin⁷, Samir parikh⁴, Hareth M. Madhoun⁸, Lee Hebert⁹, Isabelle Ayoub⁴ and Stacy P. Ardoin¹⁰, ¹The Ohio State University, The Ohio State University, Columbus, OH, ²Internal Medicine/Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH, ³The Ohio State University Wexner Medical Center, Columbus, OH, ⁴The Ohio State University, Columbus, OH, ⁵Department of Biomedical Informatics and Center for Biostatistics, The Ohio State University Wexner Medical Center, Columbus, OH, ⁶Department of Rheumatology/Medicine, Ohio State University, Columbus, OH, ⁷Ohio State University Medical Center, Columbus, OH, ⁸Rheumatology/Immunology, The Ohio State University Wexner Medical Center, Columbus, OH, ⁹Medicine, Ohio State University Medical Center, Columbus, OH, ¹⁰Pediatric & Adult Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH
Background/Purpose: : Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease which can impact the central nervous system in multiple ways, including development of cognitive…
Abstract Number: 1617 • 2017 ACR/ARHP Annual Meeting
Autoimmune Diseases in Patients with Cutaneous Lupus Erythematosus
Elaine Kunzler^1,2, Linda S. Hynan³ and Benjamin F. Chong¹, ¹Dermatology, University of Texas Southwestern Medical Center, Dallas, TX, ²Northeast Ohio Medical University, Rootstown, OH, ³Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX
Background/Purpose: Increased rates of co-existing autoimmune diseases in the systemic lupus erythematosus (SLE) population have been reported.1 Little is known about the prevalence of autoimmune…
Abstract Number: 1631 • 2017 ACR/ARHP Annual Meeting
Hospital Readmissions for SLE in the United States: A National Database Study
Narender Annapureddy¹, Aparna Saha² and Girish Nadkarni³, ¹Vanderbilt University Medical Center, Nashville, TN, ²Department of Public Health, Icahn School of Medicine at Mount Sinai, New york, NY, ³Division of Nephrology, Icahn School of Medicine at Mount Sinai, New york, NY
Hospital Readmissions For SLE In The United States: A National Database Study Background/Purpose: Systemic lupus erythematosus (SLE) is associated with significant mortality and morbidity, and…
Abstract Number: 1797 • 2017 ACR/ARHP Annual Meeting
Insights from Treating to Target in Rheumatoid Arthritis at an Academic Medical Center
Malithi Jayasundara¹, Ryan Jessee², Jason Weiner³, Tayseer Haroun⁴, Stephanie Giattino⁵, Atul Kapila⁴, Jenelle Hall⁴, Lisa Carnago⁴ and Lisa Criscione-Schreiber⁶, ¹Rheumatology, Duke University, Durham, NC, ²Department of Medicine, Division of Rheumatology and Immunology, Duke University, Durham, NC, ³Department of Medicine, Division of Rheumatology and Immunology, Duke University Medical Center, Durham, NC, ⁴Duke University, Durham, NC, ⁵Rheumatology, Duke University Medical Center, Durham, NC, ⁶Internal Medicine, Duke University Medical Center, Durham, NC
Background/Purpose: Current RA guidelines recommend treating to a target of remission or low disease activity (RM/LDA) state. In a prior quality improvement (QI) project, our…
Abstract Number: 1959 • 2017 ACR/ARHP Annual Meeting
Multimorbidity in Patients with Sarcoidosis: A Population-Based Cohort Study
Patompong Ungprasert¹, Eric L. Matteson² and Cynthia S. Crowson³, ¹Rheumatology, Mayo Clinic, Rochester, MN, ²Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN, ³Department of Medicine, Division of Rheumatology,Mayo Clinic, Rochester, MN
Multimorbidity in Patients with Sarcoidosis: A Population-Based Cohort StudyBackground/Purpose: Recent studies have suggested an increased risk of comorbidity in patients with sarcoidosis. However, whether…
Abstract Number: 2366 • 2017 ACR/ARHP Annual Meeting
High Uric Acid As a Risk Factor for Cardiovascular Diseases in Rheumatoid Arthritis Patients
Adeeba Al-Herz¹, Ali Aldei¹, Khulood Saleh², Adel Al-Awadhi³, Waleed Al-Kandari², Eman Hasan⁴, Aqeel Ghanem⁵, Mohammad Hussain⁴, Ibrahim Nahar⁵, Fatemah Abutiban⁶, Ahmad Alenizi⁶, Yaser Ali⁵, Hebah Alhajeri⁵, Sawsan Hayat⁵, Ahmad Khadrawy², Ammad Fazal², Khaled Mokaddem¹, Agaz Zaman⁵, Ghada Mazloum⁵, Youssef Bartella¹, Sally Hamed¹, Ramia Alsouk⁶ and Ahmed Al-Saber⁷, ¹Rheumatology, Al-Amiri Hospital, Kuwait city, Kuwait, ²Rheumatology, Farwania Hospital, Farwania, Kuwait, ³Faculty of Medicine, Kuwait, Kuwait, ⁴Al-Amiri Hospital, Kuwait city, Kuwait, ⁵Rheumatology, Mubarak Al-Kabeer Hospital, Hawally, Kuwait, ⁶Rheumatology, Jahra Hospital, Jahra, Kuwait, ⁷Department of Mathematics, Kuwait Technical College, Kuwait city, Kuwait
Background/Purpose: Rheumatoid arthritis (RA) patients have an increased risk of cardiovascular diseases (CVD). It is unclear whether an elevated serum uric acid (UA) further increases…
Abstract Number: 2518 • 2017 ACR/ARHP Annual Meeting
Racial Differences in Clinical Characteristics and Co-Morbidities of Ankylosing Spondylitis
Dilpreet Singh¹ and Marina N. Magrey², ¹Rheumatology, Case Western Reserve University School of Medicine at MetroHealth Medical Center, Cleveland, OH, ²Case Western Reserve University School of Medicine at MetroHealth Medical Center, Cleveland, OH
Background/Purpose: Ethnic heterogeneity of the United States (US) population makes it imperative to study the racial differences in clinical characteristics of Ankylosing Spondylitis (AS) patients,…
Abstract Number: 2921 • 2017 ACR/ARHP Annual Meeting
Improved Survival Following Renal Transplantation in Waitlisted Patients with Systemic Lupus Erythematosus in the United States
April Jorge¹, Zachary S. Wallace², Na Lu³, Yuqing Zhang⁴ and Hyon K. Choi⁵, ¹Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ²Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ³Department of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ⁴School Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ⁵Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
Background/Purpose: Lupus nephritis is a major complication of systemic lupus erythematosus (SLE), occurring in up to half all SLE patients and progressing to end-stage renal…
Abstract Number: 1303 • 2016 ACR/ARHP Annual Meeting
Extended T2-Times in Cardiovascular Magnetic Resonance (CMR) in Patients with Systemic Lupus Erythematosus (SLE) and Persisted Dyspnoea: Is SLE-Associated Myocarditis an Underestimated Problem?
Dr. Philipp Sewerin¹, Vera Lachmann², Mareike Gastl², Patrick Behm³, PD Dr. Rebecca Fischer-Betz⁴, Prof. Dr. Benedikt Ostendorf¹, Dr. Gamal Chehab⁵, Prof. Dr. Matthias Schneider¹, Prof. Dr. Malte Kelm² and Dr. Florian Bönner², ¹Department of Rheumatology & Hiller Research Unit, Heinrich-Heine University, Düsseldorf, Germany, ²Department of Internal Medicine, Division of Cardiology, Pulmology and Vascular Medicine and Molecular Cardiology, Heinrich-Heine University, Düsseldorf, Germany, ³Heinrich-Heine University, Düsseldorf, Germany, ⁴Department of Rheumatology & Hiller Research Unit, Heinrich-Heine-University, Duesseldorf, Germany, ⁵Department of Rheumatology & Hiller Research Unit, Heinrich-Heine University, 40225 Duesseldorf, Germany
Background/Purpose: To investigate the value of cardiovascular magnetic resonance (CMR) and T2-mapping in patients with systemic lupus erythematosus (SLE) and persistent dyspnoea without sings for…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].